<i>Ganoderma lucidum</i> polysaccharides ameliorate lipopolysaccharide-induced acute pneumonia via inhibiting NRP1-mediated inflammation-Reference-Cited by-同舟云学术

Ganoderma lucidum polysaccharides ameliorate lipopolysaccharide-induced acute pneumonia via inhibiting NRP1-mediated inflammation

Published:2022-11-14 Issue:1 Volume:60 Page:2201-2209
ISSN:1388-0209
Container-title:Pharmaceutical Biology
language:en
Short-container-title:Pharmaceutical Biology

Author:

Zhang Xuelian¹²³⁴,Wu Daoshun¹²³⁴,Tian Yu¹²³^ORCID,Chen Xiangdong¹²³⁴,Lan Jin¹²³⁴,Wei Fei¹²³⁴,Li Ye⁵,Luo Yun¹²³⁴,Sun Xiaobo¹²³⁴

Affiliation:

1. Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China

2. Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China

3. Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Beijing, China

4. NMPA Key Laboratory for Research and Evaluation of Pharmacovigilance, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China

5. Ganoherb (Fujian) Technology Corporation, Nanping, China

Funder

the National Key Research and Development Plan Program

CAMS Innovation Fund for Medical Sciences

Publisher

Informa UK Limited

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13880209.2022.2142615

Reference55 articles.

1. The dynamic interplay between AMPK/NFκB signaling and NLRP3 is a new therapeutic target in inflammation: Emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury